30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Strategic Initiatives

Arthrex Collaborates with CellRight Technologies on Distribution -

CellRight Technologies, entered into an agreement granting Arthrex distribution rights to its proprietary BioRinse bone portfolio in Europe, starting with the U.K. The companies entered into their first collaboration in 1Q18, addressing the U.S. BioRinse sterilization technology is applied to CellRight's orthobiologic product families of Matrix OI®, MatrixCellect® 100 DBM putty, MatrixCellect® 100 DBM Crunch, ConCelltrate® 100, etc. (Tissue Regenix Group plc, 11/13/18)